← Leaderboards
Parbara Driver
Westat, Inc.
$356,984
Attributed
$356,984
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $304.7K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$356,984 · 1
By mechanism
N01$356,984 · 1
Top collaborators
No co-investigators on record.
Most similar at Westat, Inc.
Same institution · by research overlap
- Barbara Driver$270,069,085
- Russell Walker$15,990,748
- Steve Durako$1,229,437
- Detra Robinson$15,000,418
- James J. Korelitz$28,529,612
Others in their field
Other Emerging Leaders on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Abraham Aizer Brody · New York University School Of Medicine$16,015,961
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Michael P Harms · Washington University$13,645,932
- Jorge Eduardo Chavarro · Harvard School Of Public Health$12,830,103
Research focus
WomanAntiretroviral TherapyCaringData AnalysesData SetAnti-Retroviral AgentsDrug KineticsIntegrase InhibitorsManuscriptsNational Institute Of Child Health And Human DevelopmentNewborn InfantPharmacologyPregnancyPregnant WomenProtocols DocumentationRandomized TrialRegimenRepositoryResponseReverse Transcriptase InhibitorsRisk MinimizationSafetySamplingTransmission Process
Grant awards (2)
STUDY CLOSE-OUT FOR THE RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN$52,284
N01 · FY2021 · HD · contact PI
STUDY CLOSE-OUT FOR THE RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN$304,700
N01 · FY2020 · HD · contact PI